Simplex Trading
RXRX icon

Simplex Trading’s Recursion Pharmaceuticals RXRX Stock Holding History

Simplex Trading’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Buy
+97,118
New +$375K ﹤0.01% 3826
2025
Q2 		– Sell
-481,048
Closed -$2.36M – 9595
2025
Q1 		$2.54M Buy
481,048
+217,676
+83% +$1.59M ﹤0.01% 1819
2024
Q4 		$1.78M Sell
263,372
-21,341
-7% -$143K ﹤0.01% 2297
2024
Q3 		$1.88M Buy
284,713
+189,941
+200% +$1.36M ﹤0.01% 2325
2024
Q2 		$710K Buy
94,772
+58,556
+162% +$511K ﹤0.01% 3273
2024
Q1 		$361K Buy
+36,216
New +$403K ﹤0.01% 4188
2023
Q4 		– Sell
-84,110
Closed -$600K – 9692
2023
Q3 		$643K Buy
84,110
+82,693
+5,836% +$825K ﹤0.01% 3127
2023
Q2 		$10K Buy
1,417
+494
+54% +$3.46K ﹤0.01% 7432
2023
Q1 		$6K Sell
923
-482
-34% -$3.82K ﹤0.01% 7934
2022
Q4 		$10K Sell
1,405
-1,370
-49% -$13.4K ﹤0.01% 7572
2022
Q3 		$29K Buy
+2,775
New +$28.1K ﹤0.01% 7119
2022
Q2 		– Sell
-397
Closed -$2.66K – 10930
2022
Q1 		$2K Sell
397
-485
-55% -$5.15K ﹤0.01% 9926
2021
Q4 		$15K Sell
882
-6,084
-87% -$114K ﹤0.01% 8700
2021
Q3 		$250K Sell
6,966
-100
-1% -$2.83K ﹤0.01% 5234
2021
Q2 		$257K Buy
+7,066
New +$209K ﹤0.01% 5252

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's RXRX Position: Q1 2026 in Review

Simplex Trading opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 97,118 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #3826 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RXRX as recently as Q1 2025.

Simplex Trading first reported a position in RXRX in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.54M in Q1 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Simplex Trading held 97,118 shares of Recursion Pharmaceuticals worth $298K as of Q1 2026.
  • Recursion Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3826 holding.
  • Simplex Trading first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • Simplex Trading's Recursion Pharmaceuticals position peaked at $2.54M in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.